Abstract
Purpose
The gut microbiome plays a critical role in maintaining children’s health and in preventing and treating children’s disease. Current application of the gut microbiome in childhood cancer is still lacking. This study aimed to systematically review the following: (1) alternations in the gut microbiome throughout cancer treatment trajectories in children, (2) the associations between the gut microbiome and gastrointestinal (GI) symptoms and psychoneurological symptoms (PNS), and (3) the efficacy of therapeutic interventions in the gut microbiome in children with cancer.
Methods
PubMed, EMBASE, the Cochrane Library, and the American Society of Clinical Oncology abstract were searched. Eligible studies included all study types in which the gut microbiome was primarily reported in children with cancer. The Mixed Methods Assessment Tool was used to evaluate the methodology quality of included studies. Seven studies met our eligibility criteria, including two cohort studies, two case-control studies, and three randomized controlled trails.
Results
The findings showed that the diversity estimates of the gut microbiome in children with cancer were lower than those of healthy controls both pre- and post-treatment. Children with cancer showed a significantly lower relative abundance of healthy gut microbiome (e.g., Clostridium XIVa and Bifidobacterium) during and after cancer treatment. No adequate literature was identified to support the associations between dysbiosis of the gut microbiome and GI symptoms/PNS. The use of prebiotics (fructooligosaccharides) and probiotics (Bifidobacterium or Lactobacilli) appears to improve the microenvironment of the gut around 1 month (4–5 weeks) during chemotherapy rather than at the beginning of treatment. Data also suggest that both prebiotic and probiotic interventions decrease clinical side effects (e.g., infection and morbidity risk) in children with cancer.
Conclusions
This study adds to the evidence that dysbiosis of the gut microbiome can be improved using prebiotic and probiotic supplementations in children with cancer. More well-designed experimental studies are needed to confirm this conclusion. Further studies are needed to examine the associations between the gut microbiome and GI symptoms/PNS in childhood cancer.
Similar content being viewed by others
Abbreviations
- GI:
-
Gastrointestinal
- PNS:
-
Psychoneurological symptoms
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- ALL:
-
Acute lymphoblastic leukemia
- AML:
-
Acute myeloid leukemia
- IL:
-
Interleukin
- SCFAs:
-
Short-chain fatty acids
- FOS:
-
Fructooligosaccharides
References
Knight, R. and B. Buhler, Follow your gut : the enormous impact of tiny microbes. First TED Books hardcover edition. ed. 2015. 114 pages
Savage DC (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31:107–133
Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712
Hollister EB et al (2015) Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome 3:36
Lin A, Bik EM, Costello EK, Dethlefsen L, Haque R, Relman DA, Singh U (2013) Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One 8(1):e53838. https://doi.org/10.1371/journal.pone.0053838
Wilson M (2008) Bacteriology of humans: an ecological perspective. Blackwell Pub. x, Malden, MA, 351 p
Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449(7164):811–818. https://doi.org/10.1038/nature06245
Schroeder BO, Backhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22(10):1079–1089
Slattery J, MacFabe DF, Frye RE (2016) The significance of the enteric microbiome on the development of childhood disease: a review of prebiotic and probiotic therapies in disorders of childhood. Clin Med Insights Pediatr 10:91–107. https://doi.org/10.4137/CMPed.S38338
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60. https://doi.org/10.1038/nature11450
Morgan XC et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13(9):R79
Hsiao EY et al (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155(7):1451–1463
Hill JM et al (2014) Pathogenic microbes, the microbiome, and Alzheimer’s disease (AD). Front Aging Neurosci 6:127
Garrett WS (2015) Cancer and the microbiota. Science 348(6230):80–86. https://doi.org/10.1126/science.aaa4972
Bultman SJ (2014) Emerging roles of the microbiome in cancer. Carcinogenesis 35(2):249–255
Kelly DL et al (2016) The microbiome and cancer: implications for oncology nursing science. Cancer Nurs 39(3):E56–E62
Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107(26):11971–11975. https://doi.org/10.1073/pnas.1002601107
Jost T et al (2013) Assessment of bacterial diversity in breast milk using culture-dependent and culture-independent approaches. Br J Nutr 110(7):1253–1262
Bezirtzoglou E, Tsiotsias A, Welling GW (2011) Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17(6):478–482
Lewis JD, Chen EZ, Baldassano RN, Otley AR, Griffiths AM, Lee D, Bittinger K, Bailey A, Friedman ES, Hoffmann C, Albenberg L, Sinha R, Compher C, Gilroy E, Nessel L, Grant A, Chehoud C, Li H, Wu GD, Bushman FD (2015) Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn’s disease. Cell Host Microbe 18(4):489–500. https://doi.org/10.1016/j.chom.2015.09.008
Leonard MM et al (2015) Celiac disease genomic, environmental, microbiome, and metabolomic (CDGEMM) study design: approach to the future of personalized prevention of celiac disease. Nutrients 7(11):9325–9336
Dąbrowska K, Witkiewicz W (2016) Correlations of host genetics and gut microbiome composition. Front Microbiol 7(1357)
Turpin W, Espin-Garcia O, Xu W, Silverberg MS, Kevans D, Smith MI, Guttman DS, Griffiths A, Panaccione R, Otley A, Xu L, Shestopaloff K, Moreno-Hagelsieb G, Abreu M, Beck P, Bernstein C, Dieleman L, Feagan B, Jacobson K, Kaplan G, Krause DO, Madsen K, Marshall J, Moayyedi P, Ropeleski M, Seidman E, Snapper S, Stadnyk A, Steinhart H, Surette M, Turner D, Walters T, Vallance B, Aumais G, Bitton A, Cino M, Critch J, Denson L, Deslandres C, el-Matary W, Herfarth H, Higgins P, Huynh H, Hyams J, Mack D, McGrath J, Paterson AD, Croitoru K (2016) Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet 48(11):1413–1417. https://doi.org/10.1038/ng.3693
Turpin W et al (2016) Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet
Yatsunenko T et al (2012) Human gut microbiome viewed across age and geography. Nature 486(7402):222–227
David LA et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559–563
Kang SS et al (2014) Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition. Mol Neurodegener 9:36
Xu Z, Knight R (2015) Dietary effects on human gut microbiome diversity. Br J Nutr 113(Suppl):S1–S5
Touchefeu Y et al (2014) Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis—current evidence and potential clinical applications. Aliment Pharmacol Ther 40(5):409–421
Zitvogel L et al (2016) Microbiome and anticancer immunosurveillance. Cell 165(2):276–287
Stringer AM et al (2013) Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases. Support Care Cancer 21(7):1843–1852
Galloway-Pena JR et al (2016) The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer
Coller JK, White IA, Logan RM, Tuke J, Richards AM, Mead KR, Karapetis CS, Bowen JM (2015) Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study. Support Care Cancer 23(5):1233–1236. https://doi.org/10.1007/s00520-014-2481-z
Manichanh C, Varela E, Martinez C, Antolin M, Llopis M, Dor J, Giralt J, Guarner F, Malagelada JR (2008) The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol 103(7):1754–1761. https://doi.org/10.1111/j.1572-0241.2008.01868.x
van Vliet MJ et al (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6(5):1–7
Amaral FA et al (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105(6):2193–2197
Shen, S., et al., Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci, 2017. advance online publication
Hsu YJ et al (2015) Effect of intestinal microbiota on exercise performance in mice. J Strength Cond Res 29(2):552–558
Naseribafrouei A et al (2014) Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil 26(8):1155–1162
Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305–312. https://doi.org/10.1016/j.tins.2013.01.005
Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, MacQueen G, Sherman PM (2011) Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60(3):307–317. https://doi.org/10.1136/gut.2009.202515
Wang A et al (2015) Gut microbial dysbiosis may predict diarrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One 10(5):e0126312
Dupuis LL et al (2016) Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: a prospective, longitudinal study from the Children’s Oncology Group. Cancer
Heden L et al (2013) Parents’ perceptions of their child’s symptom burden during and after cancer treatment. J Pain Symptom Manag 46(3):366–375
Van Vliet MJ et al (2009) Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin Infect Dis 49(2):262–270
Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17(2):259–275. https://doi.org/10.1079/NRR200479
Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3(3):e123–e130
Pluye P et al (2009) A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in Mixed Studies Reviews. Int J Nurs Stud 46(4):529–546
Pace R et al (2012) Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review. Int J Nurs Stud 49(1):47–53
Cozen W, Yu G, Gail MH, Ridaura VK, Nathwani BN, Hwang AE, Hamilton AS, Mack TM, Gordon JI, Goedert JJ (2013) Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins. Br J Cancer 108(5):1163–1167. https://doi.org/10.1038/bjc.2013.60
Huang Y et al (2012) Effect of high-dose methotrexate chemotherapy on intestinal Bifidobacteria, Lactobacillus and Escherichia coli in children with acute lymphoblastic leukemia. Exp Biol Med 237(3):305–311
Rajagopala SV et al (2016) Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genomics 17(1):635
Ekert H et al (1980) Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients. Med Pediatr Oncol 8(1):47–51
Zheng S et al (2006) Nutritional support of pediatric patients with cancer consuming an enteral formula with fructooligosaccharides. Nutr Res 26(4):154–162
Wada M et al (2010) Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18(6):751–759
Zwielehner J et al (2011) Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One 6(12):e28654
Richardson G, Dobish R (2007) Chemotherapy induced diarrhea. J Oncol Pharm Pract 13(4):181–198. https://doi.org/10.1177/1078155207077335
Morturano, R., Managementof chemotherapy-induced diarrhea, in OncoLink, Penn Medicine,. 2012
Miller E, Jacob E, Hockenberry MJ (2011) Nausea, pain, fatigue, and multiple symptoms in hospitalized children with cancer. Oncol Nurs Forum 38(5):E382–E393
Lyon D, Elmore L, Aboalela N, Merrill-Schools J, McCain N, Starkweather A, Elswick RK, Jackson-Cook C (2014) Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis. Biol Res Nurs 16(2):160–174. https://doi.org/10.1177/1099800413483545
Bhatt AP, Redinbo MR, Bultman SJ (2017) The role of the microbiome in cancer development and therapy. CA Cancer J Clin 67(4):326–344
Roy S, Trinchieri G (2017) Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer 17(5):271–285. https://doi.org/10.1038/nrc.2017.13
Alexander, J.L., et al., Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol, 2017. advance online publication
Montassier E et al (2015) Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 42(5):515–528
Fijlstra M, Ferdous M, Koning AM, Rings EH, Harmsen HJ, Tissing WJ (2014) Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support Care Cancer 23(6):1513–1522. https://doi.org/10.1007/s00520-014-2487-6
Montassier E et al (2014) 16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation. Microb Ecol 67(3):690–699
Paulsen JA et al (2017) Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychosocial outcomes among breast cancer survivors. Support Care Cancer
Wong ML et al (2016) Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry 21(6):797–805
Kennedy PJ, Cryan JF, Dinan TG, Clarke G (2016) Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112(Pt B):399–412. https://doi.org/10.1016/j.neuropharm.2016.07.002
Acknowledgements
We thank Dr. Becky Kinkead and Ms. Rebecca Meador from Emory University for reviewing and editing this paper.
Author information
Authors and Affiliations
Contributions
All the authors contributed to this paper and agreed with this publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Table S1
(DOC 68 kb)
Rights and permissions
About this article
Cite this article
Bai, J., Behera, M. & Bruner, D.W. The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review. Support Care Cancer 26, 427–439 (2018). https://doi.org/10.1007/s00520-017-3982-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3982-3